Arbutus Stock Soars 20%, Covid Patent Claim Against Moderna Proceeds - Arbutus Biopharma (NASDAQ:ABUS)
Arbutus Biopharma soared more than 20% on Wednesday, April 3, after the company received permission to pursue a claim against Moderna in court.
Source: benzinga.com